Zepbound fda approval date 2024?

What was the FDA approval date for Zepbound in 2024?

Zepbound (tirzepatide) received FDA approval in 2024, with its initial FDA approval date being November 8, 2023 for chronic weight management. [1]

If you meant a specific 2024 approval (such as a label expansion), those later FDA actions would depend on the exact indication and label change you’re looking for. Share the claim you saw (e.g., “for sleep apnea,” “for adolescents,” or “a new dose/indication”), and the exact 2024 approval date can be pinned to that action.

Why you might see different “approval dates” for Zepbound

Users often encounter multiple dates because:
- the original approval date can be different from later label expansions, and
- different sources sometimes list “approval” vs. “first marketed” vs. “submission approval.”

If you tell me which label statement you’re trying to verify, I can narrow it to the correct FDA action.

Where to verify the exact FDA action date

For a quick cross-check of regulatory milestones and related patent information, DrugPatentWatch.com is a useful starting point. [2]

Sources

1. https://www.fda.gov/drugs/drug-approvals-and-databases
   
2. https://www.drugpatentwatch.com/